Variant report
Variant | nsv967774 |
---|---|
Chromosome Location | chr4:100025816-100033849 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:100009811..100011847-chr4:100024562..100026344,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000197894 | chromatin interactions |
ENSG00000246090 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185455193 | chr4:100025823-100025824 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs554308529 | chr4:100025855-100025856 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs575751483 | chr4:100025862-100025863 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs2851274 | chr4:100025866-100025867 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs142940810 | chr4:100025868-100025869 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs369036931 | chr4:100025869-100025870 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs576811425 | chr4:100025880-100025881 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs58811889 | chr4:100025888-100025889 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs2602847 | chr4:100025963-100025964 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs569127392 | chr4:100025984-100025985 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs560025494 | chr4:100025989-100025990 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs530314773 | chr4:100026012-100026013 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs542460566 | chr4:100026022-100026023 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs561050206 | chr4:100026031-100026032 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs537851545 | chr4:100026039-100026040 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs563845567 | chr4:100026042-100026043 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs540224858 | chr4:100026043-100026044 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs565170861 | chr4:100026057-100026058 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs533235432 | chr4:100026081-100026082 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs1840228 | chr4:100026098-100026099 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs1840229 | chr4:100026109-100026110 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs182814848 | chr4:100026153-100026154 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs549056049 | chr4:100026164-100026165 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs145861813 | chr4:100026230-100026231 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs142593205 | chr4:100026244-100026245 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs72677574 | chr4:100026273-100026274 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs186358022 | chr4:100026283-100026284 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs536112232 | chr4:100026293-100026294 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs571174925 | chr4:100026299-100026300 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs1840230 | chr4:100026332-100026333 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs557378843 | chr4:100026367-100026368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192151143 | chr4:100026378-100026379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138602466 | chr4:100026395-100026396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182620778 | chr4:100026401-100026402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115678309 | chr4:100026405-100026406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141137208 | chr4:100026409-100026410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565256816 | chr4:100026443-100026444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1901922 | chr4:100026483-100026484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs139946695 | chr4:100026484-100026485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563441735 | chr4:100026508-100026509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530864879 | chr4:100026555-100026556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549180862 | chr4:100026584-100026585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72897134 | chr4:100026617-100026618 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs528163597 | chr4:100026627-100026628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375381358 | chr4:100026640-100026641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2851272 | chr4:100026671-100026672 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs571181447 | chr4:100026740-100026741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187697769 | chr4:100026741-100026742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550597383 | chr4:100026745-100026746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71588997 | chr4:100026769-100026770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:100012800-100063800 | Weak transcription | Aorta | Aorta |
2 | chr4:100020600-100034800 | Weak transcription | Stomach Smooth Muscle | stomach |
3 | chr4:100020800-100032800 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr4:100020800-100038600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
5 | chr4:100021000-100032200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr4:100021000-100041200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr4:100023000-100055600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr4:100025800-100038400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr4:100026200-100026400 | Enhancers | Lung | lung |
10 | chr4:100028600-100029200 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr4:100028800-100029400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:100029000-100029200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:100029000-100029400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr4:100029800-100030600 | Enhancers | Primary monocytes fromperipheralblood | blood |
15 | chr4:100031200-100031800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |